Back to search
Stage IA Non-Small Cell Lung Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stage IA Non-Small Cell Lung Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Stage IA Non-Small Cell Lung Carcinoma trials you may qualify forThis trial studies the role of the gut microbiome and effectiveness of a fecal transplant on medication-induced gastrointestinal (GI) complications in patients…
Lung cancer is the leading cause of cancer related death worldwide. Lobectomy or sub-lobectomy with mediastinal lymph node dissection is the standard surgery. A…
This is a prospective, single arm study to investigate the efficacy and safety furmonertinib 80mg/d as adjuvant treatment for 3 years post surgery of stage IA w…
This is a phase 1a/1b, open-label, multicenter, dose-escalation and dose-expansion study evaluating the safety, tolerability, antitumor activity, pharmacokineti…
This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer. Treatments for cancer can cause a pro…